Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Reb J. Russell"'
Autor:
Jun Tian, Lianchun Fan, Tapan K. Das, Giovanni Rizzi, Joon Chong Yee, Reb J. Russell, Kathleen Bierilo
Publikováno v:
Biotechnology Progress. 33:1456-1462
The long journey of developing a drug from initial discovery target identification to regulatory approval often leaves many patients with missed window of opportunities. Both regulatory agencies and biopharmaceutical industry continue to develop crea
Autor:
Ping Xu, Colleen Sparks, Charo Scott, Colleen Clark, Todd Ryder, Reb J. Russell, Michelle Wang, Jiping Zhou
Publikováno v:
Biotechnology Progress. 33:478-489
Demands for development of biological therapies is rapidly increasing, as is the drive to reduce time to patient. In order to speed up development, the disposable Automated Microscale Bioreactor (Ambr 250) system is increasingly gaining interest due
Autor:
Giovanni Rizzi, Michael Aronov, Alexis Cowan, Duncan McVey, Boaz Tirosh, John R. Megill, Charo Scott, Reb J. Russell
Publikováno v:
Biotechnology and Bioengineering. 113:1942-1952
The kinase mTOR operates in two cellular complexes, mTORC1 and mTORC2. mTORC1 adjusts metabolic activity according to external growth conditions and nutrients availability. When conditions are prosperous, mTOR facilitates protein and lipid biosynthes
Autor:
Rohini Deshpande, Scott Estes, Reb J. Russell, Anthony Lubiniecki, Trent P. Munro, Christopher C. Frye, John C. Joly, Karin Anderson, Tongtong Wang, Kathy Francissen
Publikováno v:
Biologicals. 44:117-122
Recently, several health authorities have requested substantial detail from sponsor firms regarding the practices employed to generate the production cell line for recombinant DNA-(rDNA) derived biopharmaceuticals. Two possible inferences from these
Autor:
Reb J. Russell, Lu Wang, Smith Timothy R, Sarah G. Laino, Ji Zheng, Colleen Sparks, Barbara Twarowska, Michelle Wang
Publikováno v:
Biotechnology Progress. 31:1515-1525
This article presents the use of caprylic acid (CA) to precipitate impurities from the protein A capture column elution pool for the purification of monoclonal antibodies (mAbs) with the objective of developing a two chromatography step antibody puri
Autor:
Li Tao, Ming Yao, Jinmei Fu, Tapan K. Das, Mingshe Zhu, Yunping Huang, Jacob Bongers, Reb J. Russell, Richard Ludwig, Li Ma
Publikováno v:
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
Sequence variants of a monoclonal antibody resulting from incomplete processing of signal peptide were identified and characterized using multiple mass spectrometry platforms and reverse phase chromatography. Detection and quantification of these var
Autor:
Adrienne A. Tymiak, Guodong Chen, Roxana E. Iacob, Li Tao, Jingjie Mo, John R. Engen, Reb J. Russell, Hui Wei
Publikováno v:
Drug Discovery Today. 19:95-102
The higher order structure of protein therapeutics can be interrogated with hydrogen/deuterium exchange mass spectrometry (HDX-MS). HDX-MS is now a widely used tool in the structural characterization of protein therapeutics. In this article, HDX-MS b
Autor:
Brian W. O’Mara, Reb J. Russell, Sarah G. Laino, Michelle Wang, Hui Cai, Jill Dembecki, Jian Zhang, Colleen Sparks, Neil E. Jaffe, Lu Wang
Publikováno v:
Journal of Chromatography A. 1308:86-95
Cleaning-in-place (CIP) for column chromatography plays an important role in therapeutic protein production. A robust and efficient CIP procedure ensures product quality, improves column life time and reduces the cost of the purification processes, p
Autor:
Li Tao, Zheng Jian Li, Ramji Krishnan, Jinmei Fu, Dan Huang, Jacob Bongers, Yueming Qian, Yunping Huang, Joel Goldstein, Jonathan David Basch, Reb J. Russell, Richard Ludwig, Li You
Publikováno v:
Journal of Chromatography B. 908:1-8
Low levels of alanine to serine sequence variants were identified in an IgG4 monoclonal antibody by ultra/high performance liquid chromatography and tandem mass spectrometry. The levels of the identified sequence variants A183S and A152S, both in the
Publikováno v:
Journal of Pharmaceutical and Biomedical Analysis. 59:167-172
Tris(2-carboxyethyl)phosphine (TCEP) belongs to the trialkylphosphine class of reducing agents that are widely used in research and industry. In this paper, we discuss a sensitive high-performance liquid chromatography (HPLC) method equipped with an